1.Risk Factors of Peptic Ulcer Disease in Korea.
The Korean Journal of Gastroenterology 2010;56(4):268-270
2.Helicobacter pylori Infection in Nonsteroidal Anti-inflammatory Drug Users.
The Korean Journal of Gastroenterology 2014;64(2):70-75
NSAID-induced upper gastrointestinal (GI) damage occurs easily in people with a prior history of complicated or uncomplicated ulcers. Many recent clinical studies have proved the benefit of Helicobacter pylori eradication in NSAID users; however, the exact pathophysiologic relationship between concomitant H. pylori infection and NSAID use has not yet been fully elucidated. Testing and eradication of H. pylori are generally recommended in patients who are at a high risk for NSAID-induced GI damage. However, in high-risk patients, ulcer prophylaxis with proton pump inhibitor or misoprostol is needed even if H. pylori has been successfully eradicated. In low-risk patients, it is still questionable whether or not eradication of H. pylori can reduce upper GI damage. However, in western countries, due to its cost effectiveness, testing and eradication of H. pylori is recommended before starting aspirin or NSAID irrespective of the risk level. In regions with a high prevalence of H. pylori infection (>20%), the usefulness of testing and eradication of H. pylori has not yet been determined.
Anti-Inflammatory Agents, Non-Steroidal/*therapeutic use
;
Aspirin/therapeutic use
;
Helicobacter Infections/*drug therapy
;
*Helicobacter pylori
;
Humans
;
Peptic Ulcer/*etiology
;
Proton Pump Inhibitors/therapeutic use
;
Risk Factors
3.A systematic approach for the diagnosis and treatment of idiopathic peptic ulcers.
Chen Shuan CHUNG ; Tsung Hsien CHIANG ; Yi Chia LEE
The Korean Journal of Internal Medicine 2015;30(5):559-570
An idiopathic peptic ulcer is defined as an ulcer with unknown cause or an ulcer that appears to arise spontaneously. The first step in treatment is to exclude common possible causes, including Helicobacter pylori infection, infection with other pathogens, ulcerogenic drugs, and uncommon diseases with upper gastrointestinal manifestations. When all known causes are excluded, a diagnosis of idiopathic peptic ulcer can be made. A patient whose peptic ulcer is idiopathic may have a higher risk for complicated ulcer disease, a poorer response to gastric acid suppressants, and a higher recurrence rate after treatment. Risk factors associated with this disease may include genetic predisposition, older age, chronic mesenteric ischemia, smoking, concomitant diseases, a higher American Society of Anesthesiologists score, and higher stress. Therefore, the diagnosis and management of emerging disease should systematically explore all known causes and treat underlying disease, while including regular endoscopic surveillance to confirm ulcer healing and the use of proton-pump inhibitors on a case-by-case basis.
Endoscopy, Gastrointestinal
;
Humans
;
Patient Selection
;
Peptic Ulcer/*diagnosis/etiology/*therapy
;
Predictive Value of Tests
;
Proton Pump Inhibitors/therapeutic use
;
Risk Assessment
;
Risk Factors
;
Treatment Outcome
;
Wound Healing/drug effects
4.Changes in Upper Gastrointestinal Diseases according to Improvement of Helicobacter pylori Prevalence Rate in Korea.
The Korean Journal of Gastroenterology 2015;65(4):199-204
Helicobacter pylori can cause variety of upper gastrointestinal disorders such as peptic ulcer, mucosa associated lymphoid tissue (MALT)-lymphoma, and gastric cancer. The prevalence of H. pylori infection has significantly decreased in Korea since 1998 owing to active eradication of H. pylori. Along with its decrease, the prevalence of peptic ulcer has also decreased. However, the mean age of gastric ulcer increased and this is considered to be due to increase in NSAID prescription. Gastric cancer is one of the leading causes of cancer deaths in Korea and Japan, and IARC/WHO has classified H. pylori as class one carcinogen of gastric cancer. Despite the decreasing prevalence of H. pylori infection, the total number of gastric cancer in Korea has continuously increased from 2006 to 2011. Nevertheless, the 5 year survival rate of gastric cancer patients significantly increased from 42.8% in 1993 to 67% in 2010. This increase in survival rate seems to be mainly due to early detection of gastric cancer and endoscopic mucosal dissection treatment. Based on these findings, the prevalence of peptic ulcer is expected to decrease even more with H. pylori eradication therapy and NSAID will become the main cause of peptic ulcer. Although the prevalence of gastric cancer has not changed along with decreased the prevalence of H. pylori, gastric cancer is expected to decrease in the long run with the help of eradication therapy and endoscopic treatment of precancerous lesions.
Anti-Bacterial Agents/therapeutic use
;
Anti-Inflammatory Agents, Non-Steroidal/adverse effects
;
Gastrointestinal Diseases/complications/*epidemiology
;
Helicobacter Infections/complications/drug therapy/epidemiology
;
Humans
;
Lymphoma, B-Cell, Marginal Zone/epidemiology
;
Peptic Ulcer/epidemiology/etiology
;
Prevalence
;
Stomach Neoplasms/etiology/mortality/pathology
5.Risk Factors for Development and Recurrence of Peptic Ulcer Disease.
Jin Joo KIM ; Nayoung KIM ; Byoung Hwan LEE ; Jung Mook KANG ; Pyoungju SEO ; Min Kyoung LIM ; Jung Hee KWON ; Byeong Jun SONG ; Jung Won LEE ; Sang Hyup LEE ; Young Soo PARK ; Jin Hyeok HWANG ; Jin Wook KIM ; Sook Hyang JEONG ; Dong Ho LEE ; Hyun Chae JUNG ; In Sung SONG
The Korean Journal of Gastroenterology 2010;56(4):220-228
BACKGROUND/AIMS: Peptic ulcer disease (PUD) is one of the common gastrointestinal diseases, and its medical management has been developed so much that the incidence of its serious complications, such as bleeding and perforation, are declining significantly. Its prevalence in Korea is not definitely decreased, probably due to increasing proportion of elderly patients and their rising usage of non-steroidal anti-inflammatory drugs (NSAIDs) and aspirins. This study was conducted to identify the risk factors for development and recurrence of peptic ulcer disease in Korea. METHODS: From 2003 to 2008, upper gastrointestinal endoscopy and detailed personal questionnaires were performed for patients who visited Department of Gastroenterology at Seoul National University Bundang Hospital. In total, 475 PUD patients and 335 non-ulcer dyspepsia patients were included. The results of questionnaires and repeated upper gastrointestinal endoscopy at initial diagnosis time and follow-up periods were analyzed. RESULTS: Multivariable analysis showed that male, H. pylori infection, NSAIDs use and smoking were risk factors for the development of PUD. The use of proton pump inhibitors (PPIs) and H2 receptor antagonists has significantly reduced the risk of PUD in patients who had taken NSAIDs and/or aspirins. H. pylori infection was found as the only risk factor for the recurrence of PUD. CONCLUSIONS: For the old patients who are taking drugs, such as NSAIDs and aspirins, concomitant use of PPIs or H2 receptor antagonists should be considered to protect from the development of PUD. H. pylori eradication has been confirmed again to be essential for the treatment of PUD patients infected with H. pylori.
Adult
;
Aged
;
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use
;
Aspirin/therapeutic use
;
Endoscopy, Gastrointestinal
;
Female
;
Helicobacter Infections/complications/drug therapy
;
Helicobacter pylori
;
Histamine H2 Antagonists/therapeutic use
;
Humans
;
Male
;
Middle Aged
;
Peptic Ulcer/drug therapy/*etiology
;
Proton Pump Inhibitors/therapeutic use
;
Questionnaires
;
Recurrence
;
Risk Factors
;
Sex Factors
;
Smoking
;
Stomach Ulcer/etiology
6.Long-term curative effects of suture plus proximal gastric vagotomy or triad-therapy for duodenal ulcer with acute perforation.
Ruiyun XU ; Li FANG ; Xiaochun JIANG ; Yueping WAN ; Shaowei HUANG ; Kesong JIANG ; Nan LIN ; Weidong PAN
Chinese Journal of Surgery 2002;40(9):647-649
OBJECTIVETo study the long-term curative effects of suture plus proximal gastric vagotomy (PGV) and suture plus triad-therapy (omeprazole, amoxycillin and flagyl taken orally) for the treatment of duodenal ulcer with acute perforation.
METHODSThree hundred and twenty-nine patients with duodenal ulcer and acute perforation were treated with 2 different methods, respectively. Method A was suture plus PGV (group A, 153 cases), and method B was suture plus triad-therapy (group B, 176 cases). Follow-up was made by means of correspondence, outpatient reexamination and cooperation with local hospitals in 5 to 8 years after operation. The contents of follow-up included symptom acquisition (such as upper abdominal pain or distention, pyrosis, belch, acid regurgitation, vomiting, diarrhea and conditions of living or working), gastroscopy and Helicobacter pylori (HP) detection. The curative effects were evaluated by the Visick scale.
RESULTSThree hundred and one patients were followed up (group A 142 and group B 159). According to the Visick scale, 97 (68.3%), 19 (13.4%), 13 (9.15%) and 13 (9.15%) patients in group A, and 31 (19.5%), 28 (17.6%), 24 (15.1%) and 76 (47.8%) in group B were classified as Visick I, II, III and IV respectively (Z = -9.818, P < 0.01). As for HP detection, there were 130 (91.5%) patients in group A and 94 (59.1%) in group B (chi(2) = 41.438, P < 0.01).
CONCLUSIONSThe long-term curative effects of suture plus PGV were superior to those of suture plus triad-therapy for duodenal ulcer with acute perforation although HP positive rate was higher in group A than in group B. HP infection is one of the etiological factors of duodenal ulcer. The increased excitability of the vagus nerve remains to play an important role in duodenal ulcer.
Acute Disease ; Adolescent ; Adult ; Aged ; Amoxicillin ; administration & dosage ; Drug Therapy, Combination ; Duodenal Ulcer ; drug therapy ; etiology ; surgery ; Female ; Follow-Up Studies ; Humans ; Male ; Metronidazole ; administration & dosage ; Middle Aged ; Omeprazole ; administration & dosage ; Peptic Ulcer Perforation ; drug therapy ; surgery ; Suture Techniques ; Vagotomy, Proximal Gastric ; methods
7.Comparison of Helicobacter pylori Eradication Rate in Patients with Non-ulcer Dyspepsia and Peptic Ulcer Diseases according to Proton Pump Inhibitors.
Eun Jung HONG ; Dong Il PARK ; Suk Joong OH ; Min Jun SONG ; Woo Hyuk CHOI ; Cheul Ho HONG ; Jung Ho PARK ; Hong Joo KIM ; Yong Kyun CHO ; Chong Il SHON ; Woo Kyu JEON ; Byung Ik KIM
The Korean Journal of Gastroenterology 2008;52(2):80-85
BACKGROUND/AIMS: Conflicting results have been reported whether patients with non-ulcer dyspepsia (NUD) respond differently to Helicobacter pylori (H. pylori) eradication treatment compared with patients with peptic ulcer diseases (PUD). The aim of this study was to evaluate any difference in H. pylori eradication rates between patients with NUD and PUD according to each proton pump inhibitor (PPI). METHODS: From September, 2004 to April, 2007, we retrospectively reviewed 2,297 patients with NUD (1,050 patients) or PUD (1,247 patients) infected with H. pylori. All patients received a standard 1 week triple therapy comprising of one of the five PPIs (pantoprazole, esomeprazole, omeprazole, lansoprazole, rabeprazole), clarithromycin and amoxicillin. The follow-up H. pylori test was performed 4 weeks after the completion of therapy. RESULTS: There was no significant difference in the eradication rates between the two groups. In comparison of eradication rates according to PPI, omeprazole- based triple therapy group showed higher eradication rate than other groups in patients with NUD, but not in patients with PUD. CONCLUSIONS: This study failed to show any difference in H. pylori eradication rate between patients with NUD and PUD. There is no convincing evidence that the eradication rate may be affected by different PPI.
2-Pyridinylmethylsulfinylbenzimidazoles/therapeutic use
;
Adult
;
Amoxicillin/administration & dosage
;
Anti-Bacterial Agents/administration & dosage
;
Anti-Ulcer Agents/administration & dosage
;
Clarithromycin/administration & dosage
;
Data Interpretation, Statistical
;
Drug Therapy, Combination
;
Dyspepsia/*drug therapy/etiology/microbiology
;
Enzyme Inhibitors/therapeutic use
;
Female
;
Helicobacter Infections/complications/*drug therapy/microbiology
;
*Helicobacter pylori
;
Humans
;
Male
;
Middle Aged
;
Omeprazole/analogs & derivatives/therapeutic use
;
Peptic Ulcer/*drug therapy/etiology/microbiology
;
Proton Pump Inhibitors/therapeutic use
8.Clinical observation on effect of tongfu xiere recipe in treating surgical abdominal diseases accompanied with systemic inflammatory response syndrome.
Xiao-hua XIE ; Yu-xing CHENG ; Wen-gao ZHOU
Chinese Journal of Integrated Traditional and Western Medicine 2006;26(7):594-596
OBJECTIVETo observe the effect of Tongfu Xiere Recipe (TXR) on surgical abdominal diseases accompanied with systemic inflammatory response syndrome (SIRS).
METHODSForty-six patients in the post-operational stage were treated by basic therapy, including conventional treatment and antibiotics applying, and combined use of TXR, and compared with the 43 patients treated by basic therapy alone as the control group.
RESULTSCompared with the control group, the incidence of complications in the treatment group was significantly lower (P<0.01). The incidence of multiple organ dysfunction syndrome (MODS) and the mortality in the treatment group showed an decreasing tendency. Moreover, levels of plasma endotoxin, TNF-alpha, IL-6 and IL-8 in the treatment group after treatment decreased significantly, while IL-2 level increased (P < 0.01), and showed a significant difference (P < 0.01) as compared with those in the control group.
CONCLUSIONThe combined therapy can decrease the levels of blood endotoxin and inflammation promoting cytokine and increase the level of cytokine that directly related with immune function to regulate immunity and inhibit the inflammatory reaction, and furthermore, to prevent MODS and decrease the mortality of patients with surgical abdominal diseases accompanied SIRS.
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Anti-Bacterial Agents ; therapeutic use ; Appendicitis ; complications ; surgery ; Drug Therapy, Combination ; Drugs, Chinese Herbal ; therapeutic use ; Female ; Humans ; Male ; Middle Aged ; Peptic Ulcer Perforation ; complications ; surgery ; Phytotherapy ; Postoperative Complications ; drug therapy ; Systemic Inflammatory Response Syndrome ; drug therapy ; etiology
9.Guidelines for the Diagnosis and Treatment of Helicobacter pylori Infection in Korea, 2013 Revised Edition.
Sang Gyun KIM ; Hye Kyung JUNG ; Hang Lak LEE ; Jae Young JANG ; Hyuk LEE ; Chan Gyoo KIM ; Woon Geon SHIN ; Ein Soon SHIN ; Yong Chan LEE
The Korean Journal of Gastroenterology 2013;62(1):3-26
Since the Korean College of Helicobacter and Upper Gastrointestinal Research has first developed the guideline for the diagnosis and treatment of Helicobacter pylori infection in 1998, the revised guideline was proposed in 2009 by the same group. Although the revised guideline was made by comprehensive review of previous articles and consensus of authoritative expert opinions, the evidence-based developmental process was not applied in the revision of the guideline. This new guideline has been revised especially in terms of changes in the indication and treatment of H. pylori infection in Korea, and developed by the adaptation process as evidence-based method; 6 guidelines were retrieved by systematic review and the Appraisal of Guidelines for Research and Evaluation (AGREE) II process, 21 statements were made with grading system and revised by modified Delphi method. After revision, 11 statements for the indication of test and treatment, 4 statements for the diagnosis and 4 statements for the treatment have been developed, respectively. The revised guideline has been reviewed by external experts before the official endorsement, and will be disseminated for usual clinical practice in Korea. Also, the scheduled update and revision of the guideline will be made periodically.
Amoxicillin/therapeutic use
;
Anti-Bacterial Agents/therapeutic use
;
Aspirin/therapeutic use
;
Bismuth/therapeutic use
;
Breath Tests
;
Clarithromycin/therapeutic use
;
Gastroesophageal Reflux/etiology
;
Gastroscopy
;
Helicobacter Infections/complications/*diagnosis/drug therapy
;
*Helicobacter pylori
;
Humans
;
Lymphoma, B-Cell, Marginal Zone/complications
;
Metaplasia/complications
;
Metronidazole/therapeutic use
;
Peptic Ulcer/complications/drug therapy
;
Proton Pump Inhibitors/therapeutic use
;
Republic of Korea
;
Stomach Neoplasms/complications/surgery
;
Tetracycline/therapeutic use
10.Clinical Impact of Dual Antiplatelet Therapy on Peptic Ulcer Disease.
Dae Geon AHN ; Beom Jin KIM ; Jeong Wook KIM ; Jae Gyu KIM
The Korean Journal of Gastroenterology 2014;64(2):81-86
BACKGROUND/AIMS: Increased incidence of coronary artery disease has led to the increased use of dual antiplatelet therapy composed of aspirin and clopidogrel. We investigated the incidence of gastrointestinal complications in patients who received single or dual antiplatelet therapy and analyzed their clinical characteristics in order to predict the prognostic factors. METHODS: Between January 2009 and December 2011, we retrospectively reviewed the medical records of patients who underwent coronary angiography at Chung-Ang University Hospital (Seoul, Korea). One hundred and ninety-four patients were classified into two groups: aspirin alone group and dual antiplatelet group. Clinical characteristics, past medical history, and presence of peptic ulcer were analyzed. RESULTS: During the follow-up period, 11 patients had duodenal ulcer; the event rate was 2.02% in the aspirin alone group and 9.47% in the dual antiplatelet group (hazard ratio [HR] 5.24, 95% CI 1.03-26.55, p<0.05). There was no significant difference in the rate of significant upper gastrointestinal bleeding: 0% vs. 4.2% (p=0.78). In patients who received proton pump inhibitor (PPI), 24 patients had gastric ulcer; the event rate was significantly different between the two groups: 4.87% vs. 22.98% (HR 3.40, 95% CI 1.02-11.27, p<0.05). CONCLUSIONS: Dual antiplatelet groups had a higher incidence of duodenal ulcers without significant bleeding compared with the aspirin alone group. In patients who received PPI, the dual antiplatelet therapy group had a higher incidence of gastric ulcers without significant bleeding compared with the aspirin alone group. Therefore, physicians must pay attention to high risk groups who receive dual antiplatelet therapy and aggressive diagnostic endoscopy should also be considered.
Aged
;
Anti-Inflammatory Agents, Non-Steroidal/*therapeutic use/toxicity
;
Aspirin/*therapeutic use/toxicity
;
Coronary Angiography
;
Coronary Artery Disease/*prevention & control
;
Drug Therapy, Combination
;
Female
;
Gastrointestinal Hemorrhage/chemically induced/prevention & control
;
Humans
;
Incidence
;
Male
;
Middle Aged
;
Peptic Ulcer/*diagnosis/epidemiology/etiology
;
Platelet Aggregation Inhibitors/*therapeutic use/toxicity
;
Proportional Hazards Models
;
Proton Pump Inhibitors/therapeutic use
;
Retrospective Studies
;
Risk Factors
;
Ticlopidine/*analogs & derivatives/therapeutic use/toxicity